IMMUNE PHARMACEUTICALS INC Purchase Agreements

32 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and Purchasers (August 2017)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Asset Purchase Agreement between Meda Pharma SARL and Immune Pharmaceuticals, Inc. for Ceplene and Related Assets
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2017
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and Purchasers (May 4, 2017)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and EMA Financial, LLC dated April 10, 2017
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Common Stock Purchase Agreement between Immune Pharmaceuticals Inc. and HLHW IV, LLC dated March 22, 2017
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Common Stock Purchase Agreement between Immune Pharmaceuticals Inc. and HLHW IV, LLC dated February 3, 2017
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Binding Securities Purchase Agreement between Immune Pharmaceuticals Inc., Novel Pain Therapeutics, LLC, and Maxim Pharmaceuticals, Inc.
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2016
Capital Access Agreement between Immune Pharmaceuticals Inc. and Regatta Select Healthcare, LLC (June 10, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Capital Access Agreement between Immune Pharmaceuticals Inc. and Regatta Select Healthcare, LLC (April 19, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Asset Purchase Agreement between Epicept Corporation, Maxim Pharmaceuticals, Inc., and Meda Pharma SARL (Ceplene Intellectual Property)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2012
Asset Purchase Agreement between Epicept Corporation, Epicept GmbH, and Meda AB (Ceplene Rights)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2012
Securities Purchase Agreement between EpiCept Corporation and Purchasers dated March 28, 2012
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2012
Securities Purchase Agreement between EpiCept Corporation and Purchasers (February 2012)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2012
Securities Purchase Agreement between EpiCept Corporation and Institutional Investor (March 28, 2011)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2011
Securities Purchase Agreement between EpiCept Corporation and Purchasers (February 2011)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2011
Securities Purchase Agreement between EpiCept Corporation and Purchasers (November 5, 2010)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2010
Amendment No. 1 to Securities Purchase Agreement between EpiCept Corporation and Purchasers
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2010
Securities Purchase Agreement between EpiCept Corporation and Purchasers (June 25, 2010)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2010
Securities Purchase Agreement between EpiCept Corporation and Purchasers (June 18, 2009)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Securities Purchase Agreement between EpiCept Corporation and Purchasers (February 4, 2009)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Securities Purchase Agreement between EpiCept Corporation and Purchasers (February 2009)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Securities Purchase Agreement between EpiCept Corporation and Purchasers (August 1, 2008)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2008
Securities Purchase Agreement between EpiCept Corporation and Purchasers (June 2008)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2008
Loan and Security Agreement between EpiCept Corporation, Maxim Pharmaceuticals Inc., and Hercules Technology Growth Capital, Inc. dated August 30, 2006
Loan Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
CA
2006
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and Investor (October 9, 2018)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2018
Securities Purchase Agreement between Immune Pharmaceuticals Inc. and Power Up Lending Group Ltd.
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2018
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and Purchasers (May 14, 2018)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2018
Common Stock Purchase Agreement between Immune Pharmaceuticals Inc. and HLHW IV, LLC (November 17, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Securities Purchase Agreement between Immune Pharmaceuticals, Inc. and Purchasers (November 17, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Stock Purchase Agreement between Immune Pharmaceuticals Inc. and Investor (September 6, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2016
Securities Purchase Agreement between Immune Pharmaceuticals Inc. and Purchasers (July 29, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Securities Purchase Agreement between Immune Pharmaceuticals Inc. and Purchasers (March 10, 2014)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2014